| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark T. Iwicki | Director | 2025-10-23 | 154,894 | $0.81 | $125.46kSell |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 2025-10-23 | 967 | $0.82 | $792.94Sell |
| Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | 2025-10-22 | 46,748 | $0.83 | $38.80kSell |
| Todd Bazemore | Director | 2025-10-22 | 47,768 | $0.83 | $39.65kSell |
| Darius Kharabi | CHIEF BUSINESS OFFICER | 2025-10-22 | 20,806 | $0.83 | $17.27kSell |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 2025-10-22 | 32,230 | $0.83 | $26.75kSell |
| Baker Bros Advisors LP | Insider | 2025-10-01 | 50,640 | $1.38 | $70.09kSell |
| Baker Bros Advisors LP | Insider | 2025-10-01 | 462,967 | $1.38 | $640.75kSell |
| Baker Bros Advisors LP | Insider | 2025-09-30 | 195,425 | $1.60 | $311.90kSell |
| Baker Bros Advisors LP | Insider | 2025-09-30 | 21,376 | $1.60 | $34.12kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 112.67% | 21,789,226 | $12.46M | Insider |
| Ra Capital Management LP | 91.18% | 17,634,380 | $10.09M | Insider |
| Gregory Grunberg | 28.19% | 5,451,860 | $3.12M | Insider |
| Orbimed Advisors LLC | 17.83% | 3,447,840 | $1.97M | Insider |
| Oxford Finance LLC | 8.38% | 1,620,000 | $926.64k | Insider |
| Baker Bros Advisors LP | 2.20% | 425,006 | $243.10k | Insider |
| Hongming Chen | 1.06% | 204,515 | $116.98k | Insider |
| Mark T. Iwicki | 0.54% | 103,540 | $59.22k | Insider |
| Eric Trachtenberg | 0.35% | 68,066 | $38.93k | Insider |
| Robert Bradley Paull | 0.22% | 42,361 | $24.23k | Insider |